Correlation Between Enorama Pharma and Sprint Bioscience
Can any of the company-specific risk be diversified away by investing in both Enorama Pharma and Sprint Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enorama Pharma and Sprint Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enorama Pharma AB and Sprint Bioscience AB, you can compare the effects of market volatilities on Enorama Pharma and Sprint Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enorama Pharma with a short position of Sprint Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enorama Pharma and Sprint Bioscience.
Diversification Opportunities for Enorama Pharma and Sprint Bioscience
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Enorama and Sprint is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Enorama Pharma AB and Sprint Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sprint Bioscience and Enorama Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enorama Pharma AB are associated (or correlated) with Sprint Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprint Bioscience has no effect on the direction of Enorama Pharma i.e., Enorama Pharma and Sprint Bioscience go up and down completely randomly.
Pair Corralation between Enorama Pharma and Sprint Bioscience
Assuming the 90 days trading horizon Enorama Pharma AB is expected to generate 0.7 times more return on investment than Sprint Bioscience. However, Enorama Pharma AB is 1.43 times less risky than Sprint Bioscience. It trades about -0.03 of its potential returns per unit of risk. Sprint Bioscience AB is currently generating about -0.1 per unit of risk. If you would invest 378.00 in Enorama Pharma AB on August 30, 2024 and sell it today you would lose (17.00) from holding Enorama Pharma AB or give up 4.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enorama Pharma AB vs. Sprint Bioscience AB
Performance |
| Timeline |
| Enorama Pharma AB |
| Sprint Bioscience |
Enorama Pharma and Sprint Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enorama Pharma and Sprint Bioscience
The main advantage of trading using opposite Enorama Pharma and Sprint Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enorama Pharma position performs unexpectedly, Sprint Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sprint Bioscience will offset losses from the drop in Sprint Bioscience's long position.| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
| Sprint Bioscience vs. Cantargia AB | Sprint Bioscience vs. Saniona AB | Sprint Bioscience vs. Acarix AS | Sprint Bioscience vs. Gabather AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |